Question 1

How many shares of ALXN does CAPSTONE INVESTMENT ADVISORS, LLC own?

Accepted Answer

CAPSTONE INVESTMENT ADVISORS, LLC previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC) before exiting the position in 2021-Q3.

Question 2

What is CAPSTONE INVESTMENT ADVISORS, LLC's ALXN position worth?

Accepted Answer

CAPSTONE INVESTMENT ADVISORS, LLC's ALXN position was last reported at $0 in 2021-Q3 before the exit.

Question 3

Is CAPSTONE INVESTMENT ADVISORS, LLC buying or selling ALXN?

Accepted Answer

In 2021-Q3, CAPSTONE INVESTMENT ADVISORS, LLC exited their ALXN position entirely (-100.0% change in shares).

Question 4

When did CAPSTONE INVESTMENT ADVISORS, LLC first buy ALXN?

Accepted Answer

Based on available 13F filings, CAPSTONE INVESTMENT ADVISORS, LLC first reported a position in ALXN in 2018-Q4. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2021-Q2	Decreased	868,549	-26.2%	$159.6M	0.4%	—	0
2021-Q1	Increased	1.2M	+494.6%	$180.1M	0.5%	—	69
2020-Q4	New	198,044	-	$30.9M	0.1%	—	48
2020-Q1	Exited	0	-100.0%	$0	0.0%	—	0
2019-Q4	Decreased	18,634	-33.3%	$2M	0.0%	—	0
2019-Q3	Increased	27,921	+385.8%	$2.7M	0.0%	—	42
2019-Q2	Increased	5,748	+468.6%	$753,000	0.0%	—	40
2019-Q1	Decreased	1,011	-89.6%	$137,000	0.0%	—	0
2018-Q4	New	9,723	-	$947,000	0.0%	—	35

ALXN10 quarters

ALXN
10 quarters